BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14562010)

  • 1. A multicentre phase II trial of bryostatin-1 in patients with advanced renal cancer.
    Madhusudan S; Protheroe A; Propper D; Han C; Corrie P; Earl H; Hancock B; Vasey P; Turner A; Balkwill F; Hoare S; Harris AL
    Br J Cancer; 2003 Oct; 89(8):1418-22. PubMed ID: 14562010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weekly bryostatin-1 in metastatic renal cell carcinoma: a phase II study.
    Haas NB; Smith M; Lewis N; Littman L; Yeslow G; Joshi ID; Murgo A; Bradley J; Gordon R; Wang H; Rogatko A; Hudes GR
    Clin Cancer Res; 2003 Jan; 9(1):109-14. PubMed ID: 12538458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion.
    Jayson GC; Crowther D; Prendiville J; McGown AT; Scheid C; Stern P; Young R; Brenchley P; Chang J; Owens S
    Br J Cancer; 1995 Aug; 72(2):461-8. PubMed ID: 7640233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I Committee.
    Philip PA; Rea D; Thavasu P; Carmichael J; Stuart NS; Rockett H; Talbot DC; Ganesan T; Pettit GR; Balkwill F
    J Natl Cancer Inst; 1993 Nov; 85(22):1812-8. PubMed ID: 8230261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma.
    Blackhall FH; Ranson M; Radford JA; Hancock BW; Soukop M; McGown AT; Robbins A; Halbert G; Jayson GC;
    Br J Cancer; 2001 Feb; 84(4):465-9. PubMed ID: 11263437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase I trial of bryostatin-1 in children with refractory solid tumors: a Pediatric Oncology Group study.
    Weitman S; Langevin AM; Berkow RL; Thomas PJ; Hurwitz CA; Kraft AS; Dubowy RL; Smith DL; Bernstein M
    Clin Cancer Res; 1999 Sep; 5(9):2344-8. PubMed ID: 10499603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase Ib trial of bryostatin 1 in patients with refractory malignancies.
    Grant S; Roberts J; Poplin E; Tombes MB; Kyle B; Welch D; Carr M; Bear HD
    Clin Cancer Res; 1998 Mar; 4(3):611-8. PubMed ID: 9533528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of prolonged infusion Bryostatin-1 in patients with advanced malignancies.
    Marshall JL; Bangalore N; El-Ashry D; Fuxman Y; Johnson M; Norris B; Oberst M; Ness E; Wojtowicz-Praga S; Bhargava P; Rizvi N; Baidas S; Hawkins MJ
    Cancer Biol Ther; 2002; 1(4):409-16. PubMed ID: 12432257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinoma.
    Clamp AR; Blackhall FH; Vasey P; Soukop M; Coleman R; Halbert G; Robson L; Jayson GC;
    Br J Cancer; 2003 Oct; 89(7):1152-4. PubMed ID: 14520436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of bryostatin 1 in patients with relapsed non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
    Varterasian ML; Mohammad RM; Eilender DS; Hulburd K; Rodriguez DH; Pemberton PA; Pluda JM; Dan MD; Pettit GR; Chen BD; Al-Katib AM
    J Clin Oncol; 1998 Jan; 16(1):56-62. PubMed ID: 9440723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I study of intravenous bryostatin 1 in patients with advanced cancer.
    Prendiville J; Crowther D; Thatcher N; Woll PJ; Fox BW; McGown A; Testa N; Stern P; McDermott R; Potter M
    Br J Cancer; 1993 Aug; 68(2):418-24. PubMed ID: 8347500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of bryostatin 1 in metastatic malignant melanoma.
    Propper DJ; Macaulay V; O'Byrne KJ; Braybrooke JP; Wilner SM; Ganesan TS; Talbot DC; Harris AL
    Br J Cancer; 1998 Nov; 78(10):1337-41. PubMed ID: 9823975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of patients with metastatic melanoma with bryostatin-1--a phase II study.
    Gonzalez R; Ebbinghaus S; Henthorn TK; Miller D; Kraft AS
    Melanoma Res; 1999 Dec; 9(6):599-606. PubMed ID: 10661772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase II trial of bryostatin-1 for patients with metastatic renal cell carcinoma.
    Pagliaro L; Daliani D; Amato R; Tu SM; Jones D; Smith T; Logothetis C; Millikan R
    Cancer; 2000 Aug; 89(3):615-8. PubMed ID: 10931461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized phase II study of two schedules of bryostatin-1 (NSC339555) in patients with advanced malignant melanoma: A National Cancer Institute of Canada Clinical Trials Group study.
    Tozer RG; Burdette-Radoux S; Berlanger K; Davis ML; Lohmann RC; Rusthoven JR; Wainman N; Zee B; Seymour L;
    Invest New Drugs; 2002 Nov; 20(4):407-12. PubMed ID: 12448658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemia.
    Cragg LH; Andreeff M; Feldman E; Roberts J; Murgo A; Winning M; Tombes MB; Roboz G; Kramer L; Grant S
    Clin Cancer Res; 2002 Jul; 8(7):2123-33. PubMed ID: 12114412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study.
    Nezhat F; Wadler S; Muggia F; Mandeli J; Goldberg G; Rahaman J; Runowicz C; Murgo AJ; Gardner GJ
    Gynecol Oncol; 2004 Apr; 93(1):144-8. PubMed ID: 15047228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancer.
    Zonder JA; Shields AF; Zalupski M; Chaplen R; Heilbrun LK; Arlauskas P; Philip PA
    Clin Cancer Res; 2001 Jan; 7(1):38-42. PubMed ID: 11205915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I and correlative study of combination bryostatin 1 and vincristine in relapsed B-cell malignancies.
    Dowlati A; Lazarus HM; Hartman P; Jacobberger JW; Whitacre C; Gerson SL; Ksenich P; Cooper BW; Frisa PS; Gottlieb M; Murgo AJ; Remick SC
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5929-35. PubMed ID: 14676117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of bryostatin 1 in patients with relapsed multiple myeloma.
    Varterasian ML; Pemberton PA; Hulburd K; Rodriguez DH; Murgo A; Al-Katib AM
    Invest New Drugs; 2001; 19(3):245-7. PubMed ID: 11561682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.